TEK2day FINANCE Open Terminal →

Quest Diagnostics Incorporated (DGX)

NYQ · Healthcare · Diagnostics & Research

$203.06 -0.38%

Closing price as of 2026-06-12 · Source: TEK2day Finance

1-Year Price History +15.5% over period
$213$200$188$175$162 2025-062025-092025-122026-032026-06

Key Metrics

Market Cap
$22.48B
Shares Outstanding
110.7M
P/S (TTM)
2.0x
P/E (TTM)
22.4x
Exchange
NYQ
Currency
USD

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quarterly Financials

Metric2025-06-302025-09-302025-12-312026-03-31
Revenue2.8B2.8B2.8B2.9B
Gross Profit943.0M949.0M910.0M942.0M
Operating Income438.0M386.0M386.0M404.0M
Net Income282.0M245.0M245.0M252.0M
Diluted EPS$2.47$2.16$2.18$2.24

Annual Financials

Metric2022-12-312023-12-312024-12-312025-12-31
Revenue9.9B9.3B9.9B11.0B
Gross Profit3.4B3.1B3.2B3.7B
Operating Income1.4B1.3B1.3B1.6B
Net Income946.0M854.0M871.0M992.0M
Diluted EPS$7.97$7.49$7.69$8.75
Want live quotes, estimates, SEC filings, and CEO analytics for DGX?
The free TEK2day terminal runs in your browser — type /DGX to get started.
Open DGX in the Terminal →